ATOMO DIAGNOSTICS LIMITED — Director's Dealing 2021

Nov 7, 2021

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	Atomo Diagnostics Limited
ABN	37 142 925 684

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	John Kelly
Date of last notice	20 April 2020

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct and indirect
Nature of indirect interest	The Director is a controller of Dalraida
(including registered holder)	Holdings Pty Ltd.
Note: Provide details of the circumstances giving rise to the relevant
interest.
Date of change	2 & 3 November 2021
No. of securities held prior to change	Direct
	7,370,248 fully paid ordinary shares
	2,000,000 options to acquire ordinary shares
	Indirect
	66,160,000 fully paid ordinary shares
Class	Fully paid ordinary shares
Number acquired	333,333 options
Number disposed	1,040,000 ordinary shares
	666,667 options (lapsed)
Value/Consideration	Average price per share $0.2759
Note: If consideration is non-cash, provide details and estimated valuation	(Total consideration $286,896.10)

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change Direct 7,370,248 fully paid ordinary shares 1,666,666 options to acquire ordinary shares Indirect 65,120,000 fully paid ordinary shares Nature of change On market share trades, issue of 333,333 Example: on-market trade, off-market trade, exercise of options, options per shareholder approval at the 2021 issue of securities under dividend reinvestment plan, participation in AGM and lapsing of 666,667 options (per 31 buy-back August 2021 Appendix 3H).

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

==> picture [434 x 317] intentionally omitted <==

----- Start of picture text -----

Detail of contract N/A
Nature of interest
Name of registered holder
(if issued securities)
Date of change
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration
Note: If consideration is non-cash, provide details
and an estimated valuation
Interest after change
----- End of picture text -----

Part 3 –[+] Closed period

==> picture [434 x 98] intentionally omitted <==

----- Start of picture text -----

Were the interests in the securities or contracts detailed No
above traded during a [+] closed period where prior written
clearance was required?
If so, was prior written clearance provided to allow the trade
to proceed during this period?
If prior written clearance was provided, on what date was this
provided?
----- End of picture text -----

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011